RU2009102536A - Терапевтические соединения - Google Patents
Терапевтические соединения Download PDFInfo
- Publication number
- RU2009102536A RU2009102536A RU2009102536/04A RU2009102536A RU2009102536A RU 2009102536 A RU2009102536 A RU 2009102536A RU 2009102536/04 A RU2009102536/04 A RU 2009102536/04A RU 2009102536 A RU2009102536 A RU 2009102536A RU 2009102536 A RU2009102536 A RU 2009102536A
- Authority
- RU
- Russia
- Prior art keywords
- pain
- amino
- disease
- methoxytetrahydrofuran
- purin
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract 11
- 230000001225 therapeutic effect Effects 0.000 title 1
- 208000002193 Pain Diseases 0.000 claims abstract 30
- 230000036407 pain Effects 0.000 claims abstract 29
- 230000001575 pathological effect Effects 0.000 claims abstract 12
- 101150051188 Adora2a gene Proteins 0.000 claims abstract 5
- 239000000556 agonist Substances 0.000 claims abstract 5
- 239000003814 drug Substances 0.000 claims abstract 5
- 208000032131 Diabetic Neuropathies Diseases 0.000 claims abstract 3
- 206010036105 Polyneuropathy Diseases 0.000 claims abstract 3
- 230000007824 polyneuropathy Effects 0.000 claims abstract 3
- 230000002265 prevention Effects 0.000 claims abstract 3
- 208000004454 Hyperalgesia Diseases 0.000 claims abstract 2
- 208000035154 Hyperesthesia Diseases 0.000 claims abstract 2
- 206010037779 Radiculopathy Diseases 0.000 claims abstract 2
- 230000007823 neuropathy Effects 0.000 claims abstract 2
- 201000001119 neuropathy Diseases 0.000 claims abstract 2
- 208000033808 peripheral neuropathy Diseases 0.000 claims abstract 2
- 238000002560 therapeutic procedure Methods 0.000 claims abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 16
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 9
- 206010061218 Inflammation Diseases 0.000 claims 8
- 230000004054 inflammatory process Effects 0.000 claims 8
- 239000007795 chemical reaction product Substances 0.000 claims 7
- 238000000034 method Methods 0.000 claims 7
- 230000006378 damage Effects 0.000 claims 6
- 230000000694 effects Effects 0.000 claims 6
- -1 2 -cyclopentyl Chemical group 0.000 claims 5
- 201000005569 Gout Diseases 0.000 claims 5
- 206010028980 Neoplasm Diseases 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 230000000302 ischemic effect Effects 0.000 claims 5
- 201000008482 osteoarthritis Diseases 0.000 claims 5
- 206010002383 Angina Pectoris Diseases 0.000 claims 4
- 208000036487 Arthropathies Diseases 0.000 claims 4
- 208000012659 Joint disease Diseases 0.000 claims 4
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 4
- 208000005392 Spasm Diseases 0.000 claims 4
- 208000036142 Viral infection Diseases 0.000 claims 4
- 208000027418 Wounds and injury Diseases 0.000 claims 4
- 206010003246 arthritis Diseases 0.000 claims 4
- 210000004072 lung Anatomy 0.000 claims 4
- 201000006417 multiple sclerosis Diseases 0.000 claims 4
- 210000001519 tissue Anatomy 0.000 claims 4
- 230000009385 viral infection Effects 0.000 claims 4
- 208000030507 AIDS Diseases 0.000 claims 3
- 206010001513 AIDS related complex Diseases 0.000 claims 3
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 3
- 208000008035 Back Pain Diseases 0.000 claims 3
- 208000035143 Bacterial infection Diseases 0.000 claims 3
- 206010063094 Cerebral malaria Diseases 0.000 claims 3
- 208000001640 Fibromyalgia Diseases 0.000 claims 3
- 206010018634 Gouty Arthritis Diseases 0.000 claims 3
- 208000031886 HIV Infections Diseases 0.000 claims 3
- 208000037357 HIV infectious disease Diseases 0.000 claims 3
- 206010020751 Hypersensitivity Diseases 0.000 claims 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 3
- 208000007101 Muscle Cramp Diseases 0.000 claims 3
- 101100109871 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) aro-8 gene Proteins 0.000 claims 3
- 206010035664 Pneumonia Diseases 0.000 claims 3
- 208000004550 Postoperative Pain Diseases 0.000 claims 3
- 206010063837 Reperfusion injury Diseases 0.000 claims 3
- 206010040070 Septic Shock Diseases 0.000 claims 3
- 208000006673 asthma Diseases 0.000 claims 3
- 230000001363 autoimmune Effects 0.000 claims 3
- 230000001580 bacterial effect Effects 0.000 claims 3
- 208000022362 bacterial infectious disease Diseases 0.000 claims 3
- 206010006451 bronchitis Diseases 0.000 claims 3
- 230000001684 chronic effect Effects 0.000 claims 3
- 206010012601 diabetes mellitus Diseases 0.000 claims 3
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- 201000005202 lung cancer Diseases 0.000 claims 3
- 208000020816 lung neoplasm Diseases 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 230000037390 scarring Effects 0.000 claims 3
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 claims 2
- 206010003210 Arteriosclerosis Diseases 0.000 claims 2
- 208000006820 Arthralgia Diseases 0.000 claims 2
- 208000006386 Bone Resorption Diseases 0.000 claims 2
- 206010006811 Bursitis Diseases 0.000 claims 2
- 206010006895 Cachexia Diseases 0.000 claims 2
- 206010007558 Cardiac failure chronic Diseases 0.000 claims 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims 2
- 208000011231 Crohn disease Diseases 0.000 claims 2
- 201000004624 Dermatitis Diseases 0.000 claims 2
- 201000009273 Endometriosis Diseases 0.000 claims 2
- 208000035895 Guillain-Barré syndrome Diseases 0.000 claims 2
- 206010019280 Heart failures Diseases 0.000 claims 2
- 208000032843 Hemorrhage Diseases 0.000 claims 2
- 208000007514 Herpes zoster Diseases 0.000 claims 2
- 206010023330 Keloid scar Diseases 0.000 claims 2
- 208000019693 Lung disease Diseases 0.000 claims 2
- 206010027202 Meningitis bacterial Diseases 0.000 claims 2
- 206010049567 Miller Fisher syndrome Diseases 0.000 claims 2
- 208000000112 Myalgia Diseases 0.000 claims 2
- 208000001132 Osteoporosis Diseases 0.000 claims 2
- 206010037660 Pyrexia Diseases 0.000 claims 2
- 206010039203 Road traffic accident Diseases 0.000 claims 2
- 206010049771 Shock haemorrhagic Diseases 0.000 claims 2
- 201000002661 Spondylitis Diseases 0.000 claims 2
- 208000006011 Stroke Diseases 0.000 claims 2
- 208000000491 Tendinopathy Diseases 0.000 claims 2
- 206010043255 Tendonitis Diseases 0.000 claims 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 2
- 206010052428 Wound Diseases 0.000 claims 2
- 208000026816 acute arthritis Diseases 0.000 claims 2
- 230000001154 acute effect Effects 0.000 claims 2
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 2
- 208000026935 allergic disease Diseases 0.000 claims 2
- 230000007815 allergy Effects 0.000 claims 2
- 208000011775 arteriosclerosis disease Diseases 0.000 claims 2
- 201000009904 bacterial meningitis Diseases 0.000 claims 2
- 230000024279 bone resorption Effects 0.000 claims 2
- 238000010511 deprotection reaction Methods 0.000 claims 2
- 208000006454 hepatitis Diseases 0.000 claims 2
- 231100000283 hepatitis Toxicity 0.000 claims 2
- 230000002757 inflammatory effect Effects 0.000 claims 2
- 208000014674 injury Diseases 0.000 claims 2
- 230000000968 intestinal effect Effects 0.000 claims 2
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 2
- 208000028867 ischemia Diseases 0.000 claims 2
- 230000003211 malignant effect Effects 0.000 claims 2
- 206010028417 myasthenia gravis Diseases 0.000 claims 2
- 208000008423 pleurisy Diseases 0.000 claims 2
- 208000005069 pulmonary fibrosis Diseases 0.000 claims 2
- 208000002815 pulmonary hypertension Diseases 0.000 claims 2
- 210000002345 respiratory system Anatomy 0.000 claims 2
- 210000003497 sciatic nerve Anatomy 0.000 claims 2
- 238000001356 surgical procedure Methods 0.000 claims 2
- 201000004415 tendinitis Diseases 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- PDXZVRUKHZDJHA-MDSCUQPFSA-N (2r,3r,4r,5r)-5-[6-amino-2-(2,2,3,3-tetrafluorocyclobutyl)oxypurin-9-yl]-2-(hydroxymethyl)-4-methoxyoxolan-3-ol Chemical compound CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC(OC3C(C(F)(F)C3)(F)F)=NC(N)=C2N=C1 PDXZVRUKHZDJHA-MDSCUQPFSA-N 0.000 claims 1
- FODIJMMSPSLJKT-XNIJJKJLSA-N (2r,3r,4r,5r)-5-[6-amino-2-(2,5-difluorophenoxy)purin-9-yl]-2-(hydroxymethyl)-4-methoxyoxolan-3-ol Chemical compound CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC(OC=3C(=CC=C(F)C=3)F)=NC(N)=C2N=C1 FODIJMMSPSLJKT-XNIJJKJLSA-N 0.000 claims 1
- JYOWRDDMYCFMOZ-XNIJJKJLSA-N (2r,3r,4r,5r)-5-[6-amino-2-(3,4-difluorophenoxy)purin-9-yl]-2-(hydroxymethyl)-4-methoxyoxolan-3-ol Chemical compound CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC(OC=3C=C(F)C(F)=CC=3)=NC(N)=C2N=C1 JYOWRDDMYCFMOZ-XNIJJKJLSA-N 0.000 claims 1
- YPRAZLHFKHILSL-XNIJJKJLSA-N (2r,3r,4r,5r)-5-[6-amino-2-(cyclohexylamino)purin-9-yl]-2-(hydroxymethyl)-4-methoxyoxolan-3-ol Chemical compound CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC(NC3CCCCC3)=NC(N)=C2N=C1 YPRAZLHFKHILSL-XNIJJKJLSA-N 0.000 claims 1
- ZVAGZDJXBUJVJN-XNIJJKJLSA-N (2r,3r,4r,5r)-5-[6-amino-2-(cyclopentylmethoxy)purin-9-yl]-2-(hydroxymethyl)-4-methoxyoxolan-3-ol Chemical compound CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC(OCC3CCCC3)=NC(N)=C2N=C1 ZVAGZDJXBUJVJN-XNIJJKJLSA-N 0.000 claims 1
- PVWCNEQLUBRLFH-XNIJJKJLSA-N (2r,3r,4r,5r)-5-[6-amino-2-[4-chloro-3-(trifluoromethyl)phenoxy]purin-9-yl]-2-(hydroxymethyl)-4-methoxyoxolan-3-ol Chemical compound CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC(OC=3C=C(C(Cl)=CC=3)C(F)(F)F)=NC(N)=C2N=C1 PVWCNEQLUBRLFH-XNIJJKJLSA-N 0.000 claims 1
- XHRKJFWAUMXHHT-TWBCTODHSA-N (2r,3r,4r,5r)-5-[6-amino-2-[[(2s)-butan-2-yl]amino]purin-9-yl]-2-(hydroxymethyl)-4-methoxyoxolan-3-ol Chemical compound C12=NC(N[C@@H](C)CC)=NC(N)=C2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1OC XHRKJFWAUMXHHT-TWBCTODHSA-N 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 claims 1
- 206010002329 Aneurysm Diseases 0.000 claims 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 206010061666 Autonomic neuropathy Diseases 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 208000009079 Bronchial Spasm Diseases 0.000 claims 1
- 208000014181 Bronchial disease Diseases 0.000 claims 1
- 206010006448 Bronchiolitis Diseases 0.000 claims 1
- 206010006458 Bronchitis chronic Diseases 0.000 claims 1
- 206010006482 Bronchospasm Diseases 0.000 claims 1
- 206010058019 Cancer Pain Diseases 0.000 claims 1
- 201000009030 Carcinoma Diseases 0.000 claims 1
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 208000031229 Cardiomyopathies Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 206010008479 Chest Pain Diseases 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- 208000027932 Collagen disease Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 206010010741 Conjunctivitis Diseases 0.000 claims 1
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- 206010051055 Deep vein thrombosis Diseases 0.000 claims 1
- 206010012442 Dermatitis contact Diseases 0.000 claims 1
- 208000005171 Dysmenorrhea Diseases 0.000 claims 1
- 206010013935 Dysmenorrhoea Diseases 0.000 claims 1
- 206010013975 Dyspnoeas Diseases 0.000 claims 1
- 208000014094 Dystonic disease Diseases 0.000 claims 1
- 208000005189 Embolism Diseases 0.000 claims 1
- 206010014561 Emphysema Diseases 0.000 claims 1
- 206010014824 Endotoxic shock Diseases 0.000 claims 1
- 208000007530 Essential hypertension Diseases 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 241000287828 Gallus gallus Species 0.000 claims 1
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 1
- 206010019027 Haemothorax Diseases 0.000 claims 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 claims 1
- 206010020802 Hypertensive crisis Diseases 0.000 claims 1
- 208000004575 Infectious Arthritis Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 102100020873 Interleukin-2 Human genes 0.000 claims 1
- 108010002350 Interleukin-2 Proteins 0.000 claims 1
- 206010022562 Intermittent claudication Diseases 0.000 claims 1
- 208000029523 Interstitial Lung disease Diseases 0.000 claims 1
- 206010023125 Jarisch-Herxheimer reaction Diseases 0.000 claims 1
- 208000002260 Keloid Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 208000007914 Labor Pain Diseases 0.000 claims 1
- 208000035945 Labour pain Diseases 0.000 claims 1
- 201000008197 Laryngitis Diseases 0.000 claims 1
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 claims 1
- 208000008930 Low Back Pain Diseases 0.000 claims 1
- 208000016604 Lyme disease Diseases 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 206010027476 Metastases Diseases 0.000 claims 1
- 206010028116 Mucosal inflammation Diseases 0.000 claims 1
- 201000010927 Mucositis Diseases 0.000 claims 1
- 206010049565 Muscle fatigue Diseases 0.000 claims 1
- 206010028735 Nasal congestion Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010033645 Pancreatitis Diseases 0.000 claims 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 claims 1
- 208000000450 Pelvic Pain Diseases 0.000 claims 1
- 208000005764 Peripheral Arterial Disease Diseases 0.000 claims 1
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 claims 1
- 208000004983 Phantom Limb Diseases 0.000 claims 1
- 206010056238 Phantom pain Diseases 0.000 claims 1
- 201000007100 Pharyngitis Diseases 0.000 claims 1
- 208000002151 Pleural effusion Diseases 0.000 claims 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 claims 1
- 201000001068 Prinzmetal angina Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 208000010378 Pulmonary Embolism Diseases 0.000 claims 1
- 206010037423 Pulmonary oedema Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 206010038419 Renal colic Diseases 0.000 claims 1
- 206010038563 Reocclusion Diseases 0.000 claims 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 claims 1
- 208000017442 Retinal disease Diseases 0.000 claims 1
- 206010038923 Retinopathy Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 206010048908 Seasonal allergy Diseases 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- 201000010001 Silicosis Diseases 0.000 claims 1
- 206010050207 Skin fibrosis Diseases 0.000 claims 1
- 208000007718 Stable Angina Diseases 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 208000028911 Temporomandibular Joint disease Diseases 0.000 claims 1
- 208000001435 Thromboembolism Diseases 0.000 claims 1
- 206010044248 Toxic shock syndrome Diseases 0.000 claims 1
- 231100000650 Toxic shock syndrome Toxicity 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 claims 1
- 208000009325 Variant Angina Pectoris Diseases 0.000 claims 1
- 206010047115 Vasculitis Diseases 0.000 claims 1
- 206010047249 Venous thrombosis Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 208000024716 acute asthma Diseases 0.000 claims 1
- 208000005298 acute pain Diseases 0.000 claims 1
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 claims 1
- 230000002411 adverse Effects 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 claims 1
- 229960003942 amphotericin b Drugs 0.000 claims 1
- 238000002399 angioplasty Methods 0.000 claims 1
- 239000003435 antirheumatic agent Substances 0.000 claims 1
- 230000006793 arrhythmia Effects 0.000 claims 1
- 206010003119 arrhythmia Diseases 0.000 claims 1
- 230000002917 arthritic effect Effects 0.000 claims 1
- 230000000386 athletic effect Effects 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 230000017531 blood circulation Effects 0.000 claims 1
- 210000004204 blood vessel Anatomy 0.000 claims 1
- 210000000621 bronchi Anatomy 0.000 claims 1
- 201000009267 bronchiectasis Diseases 0.000 claims 1
- 230000000747 cardiac effect Effects 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 230000035606 childbirth Effects 0.000 claims 1
- 208000023819 chronic asthma Diseases 0.000 claims 1
- 208000007451 chronic bronchitis Diseases 0.000 claims 1
- 208000019425 cirrhosis of liver Diseases 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 208000010247 contact dermatitis Diseases 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 claims 1
- 235000013365 dairy product Nutrition 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 230000003205 diastolic effect Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 208000010118 dystonia Diseases 0.000 claims 1
- 206010014599 encephalitis Diseases 0.000 claims 1
- 210000003979 eosinophil Anatomy 0.000 claims 1
- 206010015037 epilepsy Diseases 0.000 claims 1
- 230000004761 fibrosis Effects 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims 1
- 230000009610 hypersensitivity Effects 0.000 claims 1
- 230000001771 impaired effect Effects 0.000 claims 1
- 208000000509 infertility Diseases 0.000 claims 1
- 230000036512 infertility Effects 0.000 claims 1
- 231100000535 infertility Toxicity 0.000 claims 1
- 210000004969 inflammatory cell Anatomy 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 208000021156 intermittent vascular claudication Diseases 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 210000004153 islets of langerhan Anatomy 0.000 claims 1
- 210000001117 keloid Anatomy 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 208000017169 kidney disease Diseases 0.000 claims 1
- 208000030175 lameness Diseases 0.000 claims 1
- 230000003902 lesion Effects 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 210000002540 macrophage Anatomy 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 210000005075 mammary gland Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 208000004296 neuralgia Diseases 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 230000002981 neuropathic effect Effects 0.000 claims 1
- 208000021722 neuropathic pain Diseases 0.000 claims 1
- 210000000440 neutrophil Anatomy 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 230000008816 organ damage Effects 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 230000010412 perfusion Effects 0.000 claims 1
- 208000008494 pericarditis Diseases 0.000 claims 1
- 230000002085 persistent effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000037081 physical activity Effects 0.000 claims 1
- 206010035653 pneumoconiosis Diseases 0.000 claims 1
- 201000003144 pneumothorax Diseases 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 208000005333 pulmonary edema Diseases 0.000 claims 1
- 230000002685 pulmonary effect Effects 0.000 claims 1
- 230000010410 reperfusion Effects 0.000 claims 1
- 230000010076 replication Effects 0.000 claims 1
- 201000004193 respiratory failure Diseases 0.000 claims 1
- 208000037803 restenosis Diseases 0.000 claims 1
- 201000003068 rheumatic fever Diseases 0.000 claims 1
- 230000033764 rhythmic process Effects 0.000 claims 1
- 201000000306 sarcoidosis Diseases 0.000 claims 1
- 230000036573 scar formation Effects 0.000 claims 1
- 201000001223 septic arthritis Diseases 0.000 claims 1
- 230000036303 septic shock Effects 0.000 claims 1
- 230000035939 shock Effects 0.000 claims 1
- 201000009890 sinusitis Diseases 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 208000020431 spinal cord injury Diseases 0.000 claims 1
- 208000005198 spinal stenosis Diseases 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 210000002330 subarachnoid space Anatomy 0.000 claims 1
- 206010042772 syncope Diseases 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- 210000001738 temporomandibular joint Anatomy 0.000 claims 1
- 230000000451 tissue damage Effects 0.000 claims 1
- 231100000827 tissue damage Toxicity 0.000 claims 1
- 206010044652 trigeminal neuralgia Diseases 0.000 claims 1
- 239000012588 trypsin Substances 0.000 claims 1
- 231100000397 ulcer Toxicity 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
- 208000019553 vascular disease Diseases 0.000 claims 1
- 208000001319 vasomotor rhinitis Diseases 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0601397-3 | 2006-06-27 | ||
| SE0601397 | 2006-06-27 | ||
| US83740206P | 2006-08-11 | 2006-08-11 | |
| US60/837,402 | 2006-08-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2009102536A true RU2009102536A (ru) | 2010-08-10 |
Family
ID=38573394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009102536/04A RU2009102536A (ru) | 2006-06-27 | 2007-06-26 | Терапевтические соединения |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7820811B2 (enExample) |
| EP (1) | EP2081932A2 (enExample) |
| JP (1) | JP2009541437A (enExample) |
| CN (1) | CN101479268B (enExample) |
| AU (1) | AU2007263727A1 (enExample) |
| BR (1) | BRPI0713902A2 (enExample) |
| CA (1) | CA2654371A1 (enExample) |
| NZ (1) | NZ573307A (enExample) |
| RU (1) | RU2009102536A (enExample) |
| WO (1) | WO2008000744A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ573308A (en) * | 2006-06-27 | 2012-02-24 | Biovitrum Ab Publ | Adenosine derivatives for the treatment of pain |
| WO2012048013A2 (en) * | 2010-10-06 | 2012-04-12 | Inhibitex, Inc. | Phosphorodiamidate derivatives of guanosine nucleoside compounds for treatment of viral injections |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4843066A (en) | 1986-11-27 | 1989-06-27 | Nippon Zoki Pharmaceutical Co., Ltd. | Novel adenosine derivatives and pharmaceutical composition containing them as an active ingredient |
| US5968914A (en) | 1987-10-28 | 1999-10-19 | Pro-Neuron, Inc. | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| WO1991006556A1 (en) * | 1989-10-24 | 1991-05-16 | Gilead Sciences, Inc. | 2' modified oligonucleotides |
| HUT61567A (en) * | 1990-12-07 | 1993-01-28 | Sandoz Ag | Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate |
| US5705491A (en) | 1992-10-27 | 1998-01-06 | Nippon Zoki Pharmaceutical Co., Ltd. | Adenosine deaminase inhibitor |
| US5877180A (en) | 1994-07-11 | 1999-03-02 | University Of Virginia Patent Foundation | Method for treating inflammatory diseases with A2a adenosine receptor agonists |
| ES2194320T3 (es) | 1997-06-03 | 2003-11-16 | Itochu Techno Chem Inc | Sustancias naturales antivirales o antitumorales y uso de las mismas. |
| US6576619B2 (en) | 1999-05-24 | 2003-06-10 | Cv Therapeutics, Inc. | Orally active A1 adenosine receptor agonists |
| KR20050055630A (ko) | 2002-06-28 | 2005-06-13 | 이데닉스 (케이만) 리미티드 | 플라비비리다에 감염 치료를 위한 1'-, 2'- 및 3'-변형된뉴클레오시드 유도체 |
| GB0228723D0 (en) | 2002-12-09 | 2003-01-15 | Cambridge Biotechnology Ltd | Treatment of pain |
| GB0305149D0 (en) | 2003-03-07 | 2003-04-09 | Cambridge Biotechnology Ltd | Compounds for the treatment of pain |
| GB0305153D0 (en) | 2003-03-07 | 2003-04-09 | Cambridge Biotechnology Ltd | Identification of therapeutic compounds |
| GB0305150D0 (en) | 2003-03-07 | 2003-04-09 | Cambridge Biotechnology Ltd | Use of therapeutic compounds |
| GB0328323D0 (en) | 2003-12-05 | 2004-01-07 | Cambridge Biotechnology Ltd | Synthesis of 2-substituted adenosines |
| KR20070004792A (ko) | 2004-03-05 | 2007-01-09 | 캠브리지 바이오테크놀로지 리미티드 | 아데노신 수용체 작용제 |
| NZ573308A (en) | 2006-06-27 | 2012-02-24 | Biovitrum Ab Publ | Adenosine derivatives for the treatment of pain |
-
2007
- 2007-06-26 CN CN2007800239044A patent/CN101479268B/zh not_active Expired - Fee Related
- 2007-06-26 NZ NZ573307A patent/NZ573307A/en not_active IP Right Cessation
- 2007-06-26 RU RU2009102536/04A patent/RU2009102536A/ru not_active Application Discontinuation
- 2007-06-26 CA CA002654371A patent/CA2654371A1/en not_active Abandoned
- 2007-06-26 WO PCT/EP2007/056377 patent/WO2008000744A2/en not_active Ceased
- 2007-06-26 US US11/823,191 patent/US7820811B2/en not_active Expired - Fee Related
- 2007-06-26 BR BRPI0713902-0A patent/BRPI0713902A2/pt not_active IP Right Cessation
- 2007-06-26 JP JP2009517174A patent/JP2009541437A/ja not_active Withdrawn
- 2007-06-26 AU AU2007263727A patent/AU2007263727A1/en not_active Abandoned
- 2007-06-26 EP EP07786849A patent/EP2081932A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007263727A1 (en) | 2008-01-03 |
| BRPI0713902A2 (pt) | 2012-11-27 |
| WO2008000744A3 (en) | 2008-02-28 |
| US20080009461A1 (en) | 2008-01-10 |
| WO2008000744A2 (en) | 2008-01-03 |
| CN101479268B (zh) | 2012-08-08 |
| EP2081932A2 (en) | 2009-07-29 |
| NZ573307A (en) | 2012-02-24 |
| CA2654371A1 (en) | 2008-01-03 |
| JP2009541437A (ja) | 2009-11-26 |
| US7820811B2 (en) | 2010-10-26 |
| CN101479268A (zh) | 2009-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2009102512A (ru) | Терапевтические соединения | |
| EP0322384B1 (en) | Nucleosides for use in therapy | |
| RU2005105692A (ru) | 3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс-хемокинового рецептора | |
| PL181721B1 (en) | Formamide derivatives | |
| JP2007526291A (ja) | アデノシン受容体アゴニスト | |
| RU2009102531A (ru) | Терапевтические соединения | |
| JP2009541436A5 (enExample) | ||
| JP2009541438A5 (enExample) | ||
| RU2004133811A (ru) | Новые соединения | |
| AU2008249329A1 (en) | Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising the same | |
| TW201006475A (en) | HIV protease inhibitors | |
| RU2010100484A (ru) | Новые соединения 892 | |
| CN108794517B (zh) | 一种精氨酸酶抑制剂及其制备方法与用途 | |
| JP2009541437A5 (enExample) | ||
| CA2079815A1 (en) | Carbo-nucleoside derivatives | |
| US7820811B2 (en) | Pro-drugs of adenosine receptor agonists | |
| RU2837221C1 (ru) | Новые производные пирролопиримидинов | |
| RU2850229C1 (ru) | Способ получения новых производных пирролопиримидинов | |
| CN113082023A (zh) | P2x3抑制剂和p2x4抑制剂的药物组合及其应用 | |
| ZA200006036B (en) | Reduced partice size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-[4-(4-pyridyl) benzoyl] piperazine. | |
| JPH05208993A (ja) | 虚血治療用製薬組成物 | |
| JP2009518393A (ja) | がん治療用ジオキソラン誘導体 | |
| CN104672236B (zh) | 一类含双酰胺基和卤代苯结构的FXa抑制剂及其用途 | |
| WO2011103457A1 (en) | Pyrimidine derivatives | |
| CN108191758A (zh) | 一种用于血管紧张素转换酶抑制剂合成的中间体及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA94 | Acknowledgement of application withdrawn (non-payment of fees) |
Effective date: 20130329 |